Voigt J M, Topal M D
Department of Pharmacology and Toxicology, Philadelphia College of Pharmacy and Science, PA 19104, USA.
Carcinogenesis. 1995 Aug;16(8):1775-82. doi: 10.1093/carcin/16.8.1775.
The ability of Klenow polymerase I, phage T7 polymerase (Sequenase), human polymerase alpha, and human polymerase beta to synthesize past (bypass) O6-methylguanine (O6-meG) lesions was studied in the presence of MgCl2 and MnCl2. An end-labeled 16-mer primer was annealed to the 3' end of gel-purified oligodeoxyribonucleotide templates (45-mers), each containing a single O6-meG in place of one G in the sequence -G1G2CG3G4T-. Extension products were analyzed by denaturing polyacrylamide gel electrophoresis and autoradiography. A fraction of the products extended by Klenow fragment terminated either opposite or one base before O6-meG located at sites 1 and 3. Termination occurred primarily one base before O6-meG located at sites 2 and 4. The remaining fractions that bypassed the lesions represented full-length product. In control reactions, the O6-meG-containing templates were annealed with complementary 45-mers, repaired with O6-alkylguanine DNA-alkyltransferase, annealed with an excess of labeled primer, and extended by Klenow fragment. Full-length extension of > 90% was observed with each template. Primer extension past O6-meG by DNA polymerase alpha and Sequenase was partially blocked in a manner which varied with the site of O6-meG in the template while primer extension by DNA polymerase beta was completely blocked (< 2% full length extension) with O6-meG at sites 1-4. Substitution of MnCl2 for MgCl2 in the reaction mixture greatly increased the bypass of O6-meG by Klenow fragment and DNA polymerase alpha but not Sequenase or DNA polymerase beta. The increased ability of Klenow fragment to bypass O6-meG in the presence of MnCl2 was found to result from an increased incorporation of G (O6-meG at sites 1 and 2) and A (O6-meG at sites 1, 2, and 3) opposite the lesion. The results indicate that O6-meG can block in vitro polymerization by several DNA polymerases and are consistent with the observed cytotoxic effects of methylating agents on mammalian cells.
在存在MgCl₂和MnCl₂的情况下,研究了Klenow聚合酶I、噬菌体T7聚合酶(测序酶)、人聚合酶α和人聚合酶β合成跨越(绕过)O⁶-甲基鸟嘌呤(O⁶-meG)损伤的能力。将一个末端标记的16聚体引物与凝胶纯化的寡脱氧核糖核苷酸模板(45聚体)的3'末端退火,每个模板在序列-G₁G₂CG₃G₄T-中含有一个取代G的单个O⁶-meG。通过变性聚丙烯酰胺凝胶电泳和放射自显影分析延伸产物。由Klenow片段延伸的一部分产物在位于位点1和3的O⁶-meG相对处或其前一个碱基处终止。终止主要发生在位于位点2和4的O⁶-meG前一个碱基处。其余绕过损伤的部分代表全长产物。在对照反应中,将含O⁶-meG的模板与互补的45聚体退火,用O⁶-烷基鸟嘌呤DNA烷基转移酶修复,与过量的标记引物退火,并由Klenow片段延伸。每个模板均观察到>90%的全长延伸。DNA聚合酶α和测序酶对O⁶-meG的引物延伸部分受阻,其方式随模板中O⁶-meG的位点而变化,而DNA聚合酶β在1-4位点存在O⁶-meG时引物延伸完全受阻(全长延伸<2%)。在反应混合物中用MnCl₂替代MgCl₂极大地增加了Klenow片段和DNA聚合酶α对O⁶-meG的绕过,但对测序酶或DNA聚合酶β没有影响。发现在存在MnCl₂的情况下Klenow片段绕过O⁶-meG的能力增加是由于与损伤相对处G(位点1和2的O⁶-meG)和A(位点1、2和3的O⁶-meG)掺入增加所致。结果表明,O⁶-meG可阻断几种DNA聚合酶的体外聚合,这与甲基化剂对哺乳动物细胞观察到的细胞毒性作用一致。